Whereas Magdinier et al. confirmed MBD2 binding in the p16 gene promoter in colon cancer, which was revert by using 5aza-dc that clear its binding on methylation pattern, not on sequence specific [47]. Here, MBD2 is linked to colonic neoplasm.